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/by-nc-PURPOSE: To report the results from the first iteration of the European Observatory of Cataract Sur-
gery, which was initiated to track changes in surgical, antiseptic, and antibiotic practices in cataract
surgery over the coming years.
SETTING: Practicing European cataract surgeons (nZ 479).
DESIGN: Internet-based declarative questionnaire or telephone questionnaire.
METHODS: The questionnaire comprised 37 questions divided into 8 categories as follows:
screening, surgeon profile, surgical procedure used, product use before arrival at the operating
room, techniques for mydriasis and anesthesia, product use during the surgery, product use after
the patient leaves the operating room, and surgeon’s attitude to guidelines.
RESULTS: Cataract surgeons (n Z 2700) were initially contacted, of whom 479 (17.7%) were
included in the survey. The current baseline survey revealed considerable variation between coun-
tries in their implementation of infectious postoperative endophthalmitis (IPOE) prophylaxis. In
some countries, adoption of intracameral cefuroxime is almost universal, whereas in others, the
use of such prophylaxis is below one half. When intracameral cefuroxime is used, it is generally
cefuroxime powder designed for parenteral use. A preparation specifically registered for intracam-
eral use is now available, and this formulation is more commonly used in countries in which intra-
cameral cefuroxime was most widely adopted.
CONCLUSION: The baseline results from this ongoing survey suggest a considerable level of het-
erogeneity between European countries in IPOE prophylaxis. Further iterations of this survey will
monitor whether a consensus begins to emerge.
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).Infectious postoperative endophthalmitis (IPOE) is
among the most feared adverse events of cataract sur-
gery and, although rare, is always serious and
frequently sight-threatening.1
The European Team for the Prophylaxis of Infection
in Cataract Surgery (ETHICS) group is a pan-
European expert group established to examiners. Published by Elsevier Inc. on behalf of ASCRS and ESCRS. This
article under the CC BY-NC-ND license (http://creativecommons.
nd/4.0/).procedures used for the prevention of endophthalmi-
tis. Early in its deliberations, it became clear that there
was considerable variation in practices and processes
in cataract surgery between different European coun-
tries.2 In this context, a survey of cataract surgery
practice, with particular emphasis on infection pro-
phylaxis, was undertaken in 9 European countries.http://dx.doi.org/10.1016/j.jcrs.2015.06.031 2635
0886-3350
2636 EUROPEAN OBSERVATORY ON CATARACT SURGERY: 2013The present report represents the results from the
first iteration of the European Observatory of Cataract
Surgery, a survey that will be repeated in subsequent
years to monitor changes in practice in the light of
such factors as the most recently published iteration
of The European Society of Cataract and Refractive
Surgeons (ESCRS) guidelines and the availability of
new prophylactic treatments and processes.3
Although the focus of this study is the use of intra-
cameral antibiotics, many other factors during surgery
are pertinent to the prevention of IPOE. Pre- and post-
surgical procedures contribute to IPOE risk; the ESCRS
study, for example, identified a number of factors,
including the location of the incision, as risks for IPOE.4
METHODSSubjectsSurvey subjects were identified from databases of oph-
thalmologists from specialized organizations and a recruit-
ment organization (Stethos, Sevres, France) in France, the
United Kingdom, Sweden, Spain, Italy, the Netherlands,Submitted: December 17, 2014.
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J CATARACT REFRACT SURG - VBelgium, Poland, and Germany. The fieldwork was under-
taken between April 15, 2013, and May 31, 2013. The survey
was in accordance with the European Pharmaceutical Mar-
ket Research Association code of conduct.
A total of 2700 ophthalmologists were contacted. To be
eligible to participate, the surgeons were required to have
at least 5 years of practice as an ophthalmic surgeon and to
undertake at least 150 cataract operations each year. A
maximum of 3 surgeons per center was allowed. A quota
of surgeons was allocated pro-rata per country, according
to the number of ophthalmologist surgeons in each country.
A weighting adjustment was applied according to the num-
ber of cataract operations performed in each country.
The survey was undertaken via an Internet-based declar-
ative questionnaire in all countries except in Poland, the
Netherlands, and Belgium, where interviews by telephone
were preferred.QuestionnaireThe questionnaire comprised 37 questions divided into 8
categories: screening, surgeon profile, surgical procedure
used, product use before arrival at the operating room, tech-
niques for mydriasis and anesthesia, product use during the
surgery, product use after the patient leaves the operating
room, and surgeon's attitude to guidelines.RESULTSDemographicsA total of 2700 surgeons were initially contacted; af-
ter screening and allocation according to national pop-
ulations of ophthalmologists 479 (17.7% of the total
contacted), European surgeons representing 243 927
cataract operations were recruited in 9 countries
(Table 1). They had been undertaking cataract surgery
for a mean of 16.8 years. Only 3% had been operating
for more than 30 years. Of the 243 927 cataract sur-
geries represented by the cohort, the mean number
of operations per year was 509, with 33% of surgeons
undertaking between 201 and 400 operations per year
(Table 2).Table 1. Recruitment of ophthalmologists.
Country
Total
Ophthalmologist
Population
Target
Recruitment
Actual
Recruitment
France 2000 60 60
United Kingdom 630 30 30
Spain 2900 100 100
Italy 1500 100 100
Germany 2500 50 50
Sweden !200 30 19
Poland 800 40 40
Belgium 800 40 40
Netherlands 670 40 40
Total !12 000 490 479
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Table 2. Screening and demographics.
Parameter
Age (years)
30–35 11%
36–40 14%
41–45 18%
46–50 22%
51–55 18%
56–60 10%
O60 7%
Practicing cataract surgery for how long (years)
5–10 28%
11–15 21%
16–20 22%
21–30 26%
O30 3%
Annual number of cataract operations
150–200 22%
201–400 33%
401–500 18%
501–1000 21%
O1000 6%
Professional position
Hospital doctor 81%
Head of department 9%
Head of clinic/fellow 10%
Place of work
General hospital 40%
University hospital 18%
Private practice 26%
Other 16%
2637EUROPEAN OBSERVATORY ON CATARACT SURGERY: 2013Surgery was most frequently performed in the
context of a general hospital (40%) or university hospi-
tal (18%), with 26% of the procedures being performed
in private practice. The great majority (81%) of respon-
dents were hospital doctors, with 19% being either
head of clinic or head of department. Those in their
middle age dominated the age distribution.Surgical TechniqueOf all surgeries, 97.9% used phacoemulsification.
Only 0.5% of the procedures were performed with
femtosecond laser. There were no differences of note
between the countries. A clear corneal incision was
used in 65% of operations and limbal in 31%, the
remainder being scleral. There was a considerable de-
gree of heterogeneity between countries in terms of
preferred positioning of the incision; whereas the tem-
poral approach was preferred in 40% of cases overall,
in Sweden it accounted for 72% of cases, and in the
Netherlands, only 12% of surgeons used this
approach. Similarly, the Spanish cohort reported using
the supero-temporal approach in 47% of cases (versusJ CATARACT REFRACT SURG - Va group mean of 18%). Surgical technique was pre-
dominantly coaxial (65% overall) rather than
bimanual. The size of the main incision was between
2.2 and 2.7 mm in the majority (62%) of surgeries
and relatively consistent between countries.
Additional incisions were required in 86% of opera-
tions overall, with highest frequencies in the United
Kingdom, Belgium, and the Netherlands (99%). The
number of additional incisions varied considerably;
in the United Kingdom, France, Spain, and Sweden,
only one single extra incision was typically performed
(58%, 76%, and 82%, respectively), whereas in Ger-
many, Poland, Belgium, and the Netherlands, more
than one extra incision was used to a higher extent.AnesthesiaAnesthesia was almost entirely local rather than
general, with eyedrops being used most frequently
(67%) either alone or with intracameral (21%), peribul-
bar (19%), sub-tenon (9%), gel (6%), retrobulbar (5%),
and subconjunctival (1%) anesthesia. Intracameral
anesthesia is also frequently used (35% to 40%) in the
United Kingdom, Spain, and Poland.Product use Before Arrival in the Operating RoomThe use of antibiotics (topical and oral), ocular anti-
septics, eyelid hygiene, skin hygiene, and anti-
inflammatory agents is summarized in the first panel
of Figure 1.
Antibiotics (all routes of administration) were used
in 42% of cataract surgeries and anti-inflammatory
drugs (all routes of administration) by 32%. Eyelid hy-
giene was the least common procedure (23%), but
large differences between countries were observed
(58% of surgeries in Spain).
Antibiotics Before arrival at the operating room, sys-
temic or topical antibiotic was used in only rarely in
the United Kingdom (3.5%) and in Sweden (7.3%)
(versus a group mean of 42%), with much higher fig-
ures for Spain, Italy, Poland, and the Netherlands (all
greater than 65%). In the great majority of cases, anti-
biotics were administered as eyedrops (93%); use of
systemic antibiotics was reported in 14% of cases.
Ofloxacin was the most commonly used antibiotic
overall (32%), but it was very rarely used in Sweden
(0.3%), Belgium (0%), and the Netherlands (5%).
Ocular Antisepsis Ocular antiseptic use before entering
the operating facility was higher in the United
Kingdom (60% compared with a group mean of
31%) and lower in Sweden and Poland (5.5% and
7.9%, respectively). Povidone iodine was the most
frequent choice of antiseptic overall (25.8%); however,
in Sweden, where the use of ocular antiseptic was theOL 41, DECEMBER 2015
Figure 1.Use of drug treatments before during and after cataract surgery. It is likely that the values for antibiotic use during surgery are under-
estimated because some respondents appear not to have considered intracameral cefuroxime as an antibiotic used during surgery. NSAIDZ
nonsteroidal anti-inflammatory drug; ATBZ antibiotics.
2638 EUROPEAN OBSERVATORY ON CATARACT SURGERY: 2013lowest in the group (5.5% of cases), chlorhexidine was
dominating (5.5%). Picloxydine, although rarely used
elsewhere, was commonly used by French surgeons
(15%).
Eyelid Hygiene Of the 23% of surgeries in which eyelid
hygiene was used, 51% used a cleaning detergent, 48%
used eyelid pads, and 7% used gel. Use of skin hygiene
in France was more than twice the group mean (69%
versus 26%).
Anti-inflammatory Drugs Anti-inflammatory drugs
were administered in 32.5% of surgeries overall; rates
were higher in the Netherlands and Belgium (58% and
77%, respectively). The great majority of this anti-
inflammatory use was accounted for by nonsteroidal
anti-inflammatory drugs (NSAIDs), 84% overall, and
considerably less by steroids (6%) and antibiotic com-
binations of NSAIDs (6%) or steroids (6%), although in
Poland, and to a lesser extent Italy, NSAID combina-
tions with antibiotics were popular preoperatively
(21.8% and 12% respectively). In the United Kingdom,
Sweden, Belgium, and the Netherlands, more than
95% of all patients given anti-inflammatory agents
before surgery received an NSAID.
Mydriasis Mydriasis was most commonly initiated by
a nurse in the ambulatory surgical center (82%); in 14%
of cases, mydriasis was initiated at home by the pa-
tients, with the remainder initiated in the operating
room.
Surgeons rated “stable dilation” and “largest size of
dilation” as the most important factors in mydriasis.J CATARACT REFRACT SURG - VEyedrops were most commonly used when mydri-
asis was initiated in the surgical center (77% overall),
although, drug inserts were more popular in this
context (22% overall) than in mydriasis initiated at
home. Inserts were the majority choice among sur-
geons in Belgium (79%) and also commonly used in
France (55%) and the Netherlands (36%). The use of
such inserts does not yet appear to be widespread in
the other countries; the inserts are not available at all
in Poland, for example. The comparative results
should be interpreted with this in mind.
When mydriasis was initiated in the operating
room, eyedrops were used in the majority of surgeries
(56%), but intracameral injection was also commonly
used (22%).
Additional mydriasis was reported in 18.3% of cata-
ract operations overall and in up to 27% of cases in
Sweden. When additional mydriasis was required,
adrenaline (epinephrine) was the most commonly
used drug (47% overall).Product Use in the Operating RoomThe use of antibiotics, ocular antiseptics, and eyelid
and skin antisepsis is summarized in the middle panel
of Figure 1.
Antisepsis Skin disinfection was used in the great ma-
jority of cataract surgery cases (83.9% overall), with
some national variation from 100% in the Netherlands
to less than 70% in Italy and Sweden. Povidone iodine
was by far the most commonly chosen antiseptic for
skin disinfection during surgery. A notable exception
was Sweden, where it was not used at all, withOL 41, DECEMBER 2015
2639EUROPEAN OBSERVATORY ON CATARACT SURGERY: 2013surgeons preferring chlorhexidine (used in 60.3% of all
surgeries). Other antiseptics such as picloxydine,
alcohol, and povidone were used much less
frequently.
The use of antiseptics for eye disinfection followed a
similar pattern to skin disinfection (instillation into the
conjunctival sac), being used in 81.1% of surgeries
overall.
Antibiotics Antibiotics (regardless of route of adminis-
tration) were used during surgery in 75.6% of all pro-
cedures (Figure 1, middle panel) and inmore than 90%
of surgeries in Spain, Poland, Belgium, and the
Netherlands, although somewhat less frequently in
the United Kingdom (63.8%) and Italy (54.6%). In Swe-
den, 51.2% of surgeons reported antibiotic use during
surgery but 100% reported using intracameral antibi-
otics. This paradox is possibly caused by an ambig-
uous translation of this specific question into the
Swedish language.
Cefuroxime was the antibiotic most frequently cho-
sen for use during surgery (41.9% of all surgeries; 93%
direct intracameral injection, 3% conjunctival, 2% by
infusion in the irrigation bottle, and 1% each as
eyedrops or intravenous), although in Germany there
was a preference for gentamicin over cefuroxime
(39.8% versus 14.6%, all routes of administration). In
the operating room, no other antibiotic was used in
more than 10% of surgeries overall, although vanco-
mycin and levofloxacin were used more commonly
in Germany than other countries (22.9% and 12.1%,
respectively, versus group means of 8.3% and 7.1%,
respectively, all routes of administration). Tobramycin
and moxifloxacin more commonly used in Spain than
other countries (10.7% and 12.7%, respectively, versus
group means of 3.9% and 3.4%, respectively, all routes
of administration). Antibiotic choice was more hetero-
geneous in Italy than in other countries; cefuroxime re-
mained the most popular choice but was used less
frequently than in the other countries (13.8% versus
a group mean of 41.9%, all routes of administration).Table 3. Route of administration of antibiotics administered in the oper
Overall Use Intracameral Eyedrops
Cefuroxime 42% 93% 1%
Gentamycin 11% 10% 9%
Vancomycin 8% 31%
Levofloxacin 7% 83%
Tobramycin/dexamethasone 4% 6%
Tobramycin 4% 4% 41%
Moxifloxacin 3% 17% 79%
Ofloxacin 2% 99%
Chloramphenicol 1% 56%
J CATARACT REFRACT SURG - VGentamycin, vancomycin, and levofloxacin were
used with approximately equal frequency (11.4%,
9.8% and 11.6%, respectively, all routes of administra-
tion). In Poland cefuroxime, both intracameral and
topical was used in 27.3% of cases only, and levoflox-
acin, moxifloxacin, and ofloxacin were used more
commonly than in the group as a whole.
The great majority of cefuroxime use was by direct
intracameral injection (93%); vancomycin and genta-
mycin were also administered by direct intracameral
injection (31% and 10% respectively), but the majority
of their use was in the irrigation fluid (69% and 41%
respectively). Tobramycin/dexamethasone was given
predominantly as an ointment (91%) and levofloxacin
as eyedrops or intravenously (83% and 15%, respec-
tively) (Table 3).
Intracameral antibiotics were used routinely by 66%
of surgeons overall, most commonly in Sweden and
Spain (100% and 95% respectively), and least
frequently in Germany and the Netherlands (36%
and 40%, respectively). Twenty-nine percent of sur-
geons stated that they did not use intracameral antibi-
otic during surgery, whereas 5% reported using
intracameral antibiotics only in specific patient
groups, most frequently in those with diabetes (22%),
those considered at risk of infection (22%), or those
with a history of eye infection (18%). Of the surgeons
who used intracameral antibiotics either routinely or
in particular patient groups, 77% reported that the
antibiotic injection was prepared by operating nurses.
In the remainder, the injection was prepared by an in-
ternal pharmacy (20%), an external provider (9%), or
by the surgeon (7%). Although branded cefuroxime
was used by most surgeons (66%) for intracameral in-
jection, 35% were already using the recently licenced
product (Aprokam); the remainder continued to pre-
pare intracameral injection by dilution of injectable
brands. The remainder used predominantly generic
cefuroxime (Figure 2).
Of the surgeons who used dilute, off-label antibi-
otics for intracameral injection, 4% reported issues,ating room in cataract surgery.
Ointment Sub-conjunctival Irrigation Fluid Intravenous
3% 2% 1%
20% 19% 41% 2%
69%
2% 15%
91% 3%
27% 1% 26% 1%
4%
1%
44%
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Figure 2. Use of intracameral (IC) antibiotics during surgery.
2640 EUROPEAN OBSERVATORY ON CATARACT SURGERY: 2013predominantly dilution errors (73%). Of the few sur-
geons who had issues, the reported consequences
were epithelial wound-healing disorders and inflam-
mation in equal number.Product Use After the Patient Leaves the Operating
RoomThe use of antibiotics and anti-inflammatory prod-
ucts is summarized in the right-hand panel of Figure 1.
Antibiotics Antibiotics (not including fixed combina-
tion with other agents) were prescribed in 44% of sur-
geries, 93% in eyedrops, 8% orally, and 3% as
ointment. A variety of drugs were used topically, but
tobramycin, ofloxacin, levofloxacin, chloramphenicol,
mofloxacin, and azithromycin together accounted for
68% of all surgeries when topical antibiotics were
used (22%, 22%, 12%, 11% and 10% and 7%, respec-
tively). Azithromycin, gentamicin, ciprofloxacin,
amoxicillin, and other antibiotics were all below
10%. Antibiotic treatment was typically commenced
on the day of surgery or the day after. Antibiotics pre-
scribed after surgery were predominantly eyedrops to
be administered 3 to 5 times daily. For those given
orally (8%), ofloxacin, amoxicillin, and cefuroxime
were most frequently used (34%, 34%, and 16%
respectively).
In addition, a fixed combination of steroid/antibi-
otic was used in 43% of cases and nonsteroidal anti-
inflammatory–antibiotic agent in 5% of cases,
predominantly topically.
There was a considerable degree of variation in the
use of antibiotics between countries (Figure 3); in
the United Kingdom, 89% of patients were prescribedJ CATARACT REFRACT SURG - Vantibiotics after surgery and 70% of these patients
received chloramphenicol, an antibiotic that
was used infrequently, if at all, in other countries.
In Sweden, the Netherlands, and Belgium, antibiotics
(as single agents, not including fixed combinations
with anti-inflammatory drugs) were used in less
than one fifth of surgeries (13.1% 17%, and 18.7%
respectively). There appeared to be little obvious
pattern in the choice of antibiotic; although tobramy-
cin was most frequently used, it was not used at all in
Germany and only rarely in the United Kingdom.
Ofloxacin, the second most common choice overall,
was the most popular antibiotic in Germany, Italy,
Poland, and the Netherlands but was not used at
all in Spain or Sweden and only occasionally in
Belgium.Anti-inflammatory Drugs Anti-inflammatory drugs
were widely used postoperatively (93% overall either
administered alone or in fixed combinations with an
antibiotic), and, of these, steroid/antibiotic combina-
tions were most commonly used (47%), typically as
eyedrops (94%). In 62% of cases receiving antibiotics,
a duration of more than 2 weeks was used and 44%
of treatments were tapered. NSAIDs were also
commonly used (40%), again most frequently as
eyedrops (95%) and usually with a duration of more
than 2 weeks (71%). Steroids were given in 34% of
cases, 95% as eyedrops. NSAID/antibiotic combina-
tions were used less frequently (5%). Anti-
inflammatory medication was generally started on
the day of surgery or the day after and was usually
continued for more than 2 weeks. Fixed combinationsOL 41, DECEMBER 2015
Figure 3. Administration of antibiotics (ATB) after the patient leaves the operating room.
2641EUROPEAN OBSERVATORY ON CATARACT SURGERY: 2013of antibiotic and anti-inflammatory drugs were very
infrequently used in Sweden (0.6%).GuidelinesMost commonly, surgeons reported following local
hospital guidelines (41% overall), although scientific
society and national guidelines were also considered
important (32% for each), but European guidelines
less so (13%). Only 8% of respondents reported that
they did not follow any guidelines.
There were considerable national differences in the
adoption of guidelines. (Figure 4)
DISCUSSION
The present study provides a baseline for an annual
series of updates of the European Observatory on
Cataract Surgery, ahead of anticipated updated
ESCRS guidelines and the more widespread introduc-
tion of licensed intracameral cefuroxime.
Considerable variation is evident in most variables
examined in this study; with the exception of the
near universal adoption of phacoemulsification,
almost every aspect of cataract surgery, from the tech-
nique and placement of the main incision to the choice
of postoperative antibiotic prophylaxis, appears to be
the subject of considerable diversity. However, it is
in the main topic of this study, prophylaxis against
IPOE, that such variability in national practice is
most evident. Before arrival at the operating room,J CATARACT REFRACT SURG - Vthe use of antibiotics (both oral and topical) ranged be-
tween 4% and 80%, ocular antiseptic between 5% and
60%, eyelid hygiene between 1% and 58%, and skin
hygiene between 4% and 69%. Similar heterogeneity
was observed in the choice of oral and topical antibi-
otics used before arrival at the operating room and
those used in the operating room, although (with the
exception of Sweden) a consistent preference for povi-
done iodine as ocular antiseptic was evident.
For a procedure as common as cataract surgery,
such wide variation in practice patterns might appear
surprising. However, the national differences prob-
ably reflect a surgical procedure in the process of
change, particularly in the context of efforts to reduce
IPOE as well as the reliance on local rather than inter-
national guidelines evident in this study. The wide-
spread use of antisepsis and antibiotic use reported
during and after cataract removal clearly attests to a
considerable emphasis on IPOE prophylaxis. Howev-
er, despite IPOE being the most unwelcome complica-
tion of cataract surgery, there appears to be little
consensus, at least among the sample polled in this
survey regarding the optimal methodology for pre-
vention of IPOE.
The seriousness of IPOE makes it is reasonable to
take measures above and beyond strict antiseptic pro-
cedures to avoid it. The history of intracameral cefur-
oxime commenced in Sweden, where preliminary
studies showed it to be effective in reducing the inci-
dence of IPOE.5 A subsequent large, prospective,OL 41, DECEMBER 2015
Figure 4. Adoption of guidelines.
2642 EUROPEAN OBSERVATORY ON CATARACT SURGERY: 2013randomized international study showed a convincing
clinical benefit.4 In Sweden, as evidenced in the cur-
rent study, the use of intracameral cefuroxime is
almost universal. In the present study, intracameral ce-
furoxime was used routinely in two thirds of cataract
removal procedures, although national differences
were significant; in Sweden and Spain, almost all pro-
cedures used intracameral cefuroxime, whereas in
Germany and Holland it was used in less than half
the procedures. Only 29% of surgeons did not use in-
tracameral cefuroxime at all, the remaining 5%
reserving it for patients at particular risk or those
who had a history of eye infection, diabetic patients,
and others considered to be at particular risk.
At present, only a single formulation of intracameral
cefuroxime is licensed (Aprokam/Aprok/Prokam,
Laboratoires Thea, Clermont Ferrand, France)
Europe-wide, but even this was not universally avail-
able at the time of this study. Not surprisingly, the use
of the licensed product was more common in those
countries where it has been available for the longest
time. Preparation of intracameral cefuroxime by dilu-
tion of branded or generic parenteral formulations is
also used by some surgeons in countries where the
licensed formulation is available, presumably as
parenteral cefuroxime is considered cheaper than the
licensed alternative, although the possible conse-
quences of dilution errors and the cost of preparation
are not taken into account.
Preparing a solution of cefuroxime suitable for intra-
cameral injection from powder designed to be used forJ CATARACT REFRACT SURG - Vparenteral systemic administration requires a number
of sequential steps that increase the risk of dilution er-
rors as well as the possibility of contamination,
although in the present study, respondents seemed
relatively unconcerned about such issues. A strong
preference for the availability of commercially pre-
pared cefuroxime preparations specifically designed
for the intracameral route has been voiced in other
contexts.6 The relative unavailability of a specific regis-
tered formulation is believed to be responsible, at least
in part, for the slow adoption of intracameral cefurox-
ime into clinical practice.7–9 Moreover, the accuracy of
dilutions can depend on the exact protocol used, and
the single-use nature of the commercial preparation
helps further reduce the risk of microbial contamina-
tion.7–9 In a previous phone survey, 77% of 250 ESCRS
members interviewed said they always or usually use
intracameral antibiotics in their cataract surgery proce-
dures. The most frequently cited reasons for not using
cefuroxime or other intracameral antibiotics was the
lack of an approved commercial preparation and
related anxieties regarding the risk of dilution errors
and contamination. More than 90% of respondents
said they would use cefuroxime if an approved sin-
gle-unit–dose product were commercially available.
Sweden presents somewhat of a special case in that
the use of intracameral cefuroxime during cataract sur-
gery is very widespread, which seems to have effects
on the other decisions in IPOE prophylaxis: use of pre-
operative antibiotics is considerably lower than in
other countries (7.3% versus a group mean of 42%);OL 41, DECEMBER 2015
2643EUROPEAN OBSERVATORY ON CATARACT SURGERY: 2013chlorhexidine was preferred over povidone iodine for
intra-surgical skin disinfection; eyelid hygiene was
practiced far less frequently than in most countries; in-
tracameral cefuroxime was, in 90% of cases, adminis-
tered as the registered preparation rather than
diluted from generic parenteral cefuroxime; and
finally, Sweden had the lowest rate of post-surgical
antibiotic prescription. It is also evident that a closer
consensus on procedure exists among Swedish
ophthalmic surgeons than among their colleagues in
other countries, despite the absence of any formal na-
tional guidelines in Sweden.
The results of the European Observatory on Cata-
ract Surgery 2014 and its subsequent iterations are
anticipated with interest to determine how national
and international practice alters with changes to
ESCRS guidelines and more widespread availability
of registered formulation of intracameral cefuroxime.WHAT WAS KNOWN
 A variety of means exist for the prophylaxis of IPOE during
cataract surgery.
 Recent studies indicate that the use of intracameral cefur-
oxime significantly reduces the risk of IPOE associated
with cataract surgery.WHAT THIS PAPER ADDS
 There was a very large degree of national heterogeneity in
the use of intracameral cefuroxime.
 Most intracameral cefuroxime was prepared locally from
preparations intended for parenteral use.
 This study provides a baseline to monitor changes in the
adoption of intracameral cefuroxime as a specific intra-
cameral formulation becomes more available.J CATARACT REFRACT SURG - VREFERENCES
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